Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_assertion type Assertion NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_head.
- NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_assertion wasGeneratedBy ECO_0000203 NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_provenance.
- NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_assertion wasDerivedFrom lhgdn-20090331 NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_provenance.
- NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_assertion SIO_000772 19139306 NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_provenance.
- NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_assertion evidence source_evidence_literature NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_provenance.
- NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_assertion description "[We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia/severity of EA6 symptoms is related to the extent of glutamate transporter dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_provenance.